Browse > Article

Antiobesity Effect of Recombinant Human Caseinomacropeptide tide in Sprague-Dawley Rat  

Kim Yu-Jin (Department of Chemical Engineering, Pusan National University, Institute for Environmental Technology and Industry, Pusan National University)
Oh You-Kwan (Department of Chemical Engineering, Pusan National University, Institute for Environmental Technology and Industry, Pusan National University)
Yoo Seung-Shick (Department of Chemical Engineering, Pusan National University)
Park Kun-Young (Department of Food Science and Nutrition, Pusan National University)
Kang Whankoo (Department of Chemical Engineering and Nano-Bio Technology, Hannam University)
Park Sunghoon (Department of Chemical Engineering, Pusan National University, Institute for Environmental Technology and Industry, Pusan National University)
Publication Information
Biotechnology and Bioprocess Engineering:BBE / v.10, no.3, 2005 , pp. 242-247 More about this Journal
Abstract
Caseinomacropeptide (CMP) is a glycopeptide of 64 amino acid residues derived from the C-terminal of mammalian milk K-casein. Recently, human CMP (hCMP) was produced from the recombinant yeast Saccharomyces cerevisiae. In this study, the antiobesity activity of the recombinant hCMP (rhCMP) was investigated in vivo using Sprague-Dawley rats. The rhCMP did not affect the rats fed with a normal fat diet (fat content, $5.0\%$), but decreased the body weight gain of the rats fed with a high fat diet (fat content, $20\%$) by up to $19\%$. Autopsies revealed that the weights of the liver, kidney and adipose tissues decreased when the rats were given the rhCMP, which also reduced the lipid concentrations in the plasma and liver, but enhanced the fecal excretion of lipids. These results suggest that rhCMP prevent the accumulation of lipid by stimulating its fecal excretion, so could be used as a food supplement to alleviate the obesity problem caused by a high fat diet.
Keywords
caseinomacropeptide; antiobesity; rat; food intake; cholecystokinin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Izzo, R. S., W. R. Brugge, and M. Praissman (1984) Immunoreactive cholecystokinin in human and rat plasma: Correlation of pancreatic secretion in response to CCK. Regul. Pept. 9: 21-34   DOI   PUBMED   ScienceOn
2 Beucher, S., F. Levenez, M. Yvon, and T. Corring (1994) Effect of caseinomacropeptide (CMP) on cholecystokinin (CCK) release in rats. Reprod. Nutr. Dev. 34: 613-614   DOI
3 Yvon, M., S. Beucher, P. Guilloteau, I. Le Huerou-Luron, and T. Corring (1994) Effects of caseinomacropeptide (CMP) on digestion regulation. Reprod. Nutr. Dev. 34: 527-537   DOI   ScienceOn
4 Sharma, N., S. M. Park, T. H. Kwon, D. H. Kim, and M. S. Yang (2004) A simple purification procedure of biologically active recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF) secreted in rice cell suspension culture. Biotechnol. Bioprocess Eng. 9: 423-427   DOI   ScienceOn
5 Ramisetti, S., H. A. Kang, S. K. Rhee, and C. H. Kim (2003) Production of recombinant hirudin in galactokinase- deficient Saccharomyces cerevisiae by fed-batch fermentation with continuous glucose feeding. Biotechnol. Bioprocess Eng. 8: 183-186   DOI   ScienceOn
6 Roy, S. K., Y. Chiba, and Y. Jigami (2000) Production of therapeutic glycoproteins through the engineering of glycosylation pathway in yeast. Biotechnol. Bioprocess Eng. 5: 219-226   DOI
7 Chernikov, M. P., E. Y. Stan, L. S. Vasilevskaya, and G. K. Shlygin (1979) Heterogeneity of $\kappa$-casein glycomacropeptide and the physiological activity of its fractions. Vopr. Pitan. 5: 22-26
8 Levin, B. E., A. A. Dunn-Meynell, B. Balken, and R. E. Keesey (1997) Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rat. Am. J. Physiol. 273: R725-R730
9 Park, S. M., A. Y. Mo, Y. S. Jang, J. H. Lee, M. S. Yang, and D. H. Kim (2004) Expression of a functional human tumor necrosis factor-$\alpha$ (hTNF-$\alpha$) in yeast Saccharomyces cerevisiae. Biotechnol. Bioprocess Eng. 9: 292-296   DOI   ScienceOn
10 Ledoux, N., S. Sahe, M. Duarry, M. Bourras, R. Benamouzig, and D. Tome (1999) Intraluminal immunoreactive caseinomacropeptide after milk protein ingestion in humans. Nahrung 43: 196-200   DOI   ScienceOn
11 Mangel, A. W. and A. Koegel (1984) Effects of peptides on gastric emptying. Am. J. Physiol. 246: G342-G345
12 Sacks, F. M. and M. Katan (2002) Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am. J. Med. 113: 13S-24S   DOI   ScienceOn
13 Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, D. Rabinowitz, R. L. Lallone, S. K. Burley, and J. M. Friedman (1995) Weight-reducing effects of plasma protein encoded by the obese gene. Science 269: 543-546   DOI   PUBMED
14 Sollier, C. B. D., L. Drouet, G. Pignand, C. Chevallier, J. Caen, A. M. Fiat, C. Izquierdo, and P. Jolles (1996) Effect of $\kappa$- casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig. Thromb. Res. 81: 427-437   DOI   ScienceOn
15 Beucher, S., F. Levenez, M. Yvon, and T. Corring (1994) Effects of gastric digestive products from casein on CCK release by intestinal cells in rat. J. Nutr. Biochem. 5: 578- 584   DOI   ScienceOn
16 Abbasi, F., T. McLaughlin, C. Lamendola, H. S. Kim, A. Tanaka, T. Wang, K. Nakajima, and G. M. Reaven (2000) High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk. Am. J. Cardiol. 85: 45-48   DOI   PUBMED   ScienceOn
17 Folch, J. M., G. Lees, and H. S. Stanley (1957) A simple method for the isolation, and purification of total lipid from animal tissue. J. Biol. Chem. 223: 497-509
18 Owyang, C. (1996) Physiological mechanisms of cholecystokinin action on pancreatic secretion. Am. J. Physiol. 271: G1-   DOI
19 Bray, G. A. and F. L. Greenway (1999) Current and potential drugs for treatment of obesity. Endocr. Rev. 20: 805-875   DOI   ScienceOn
20 Ghibaudi, L., J. Cook, C. Farley, M. van Heek, and J. J. Hwa (2002) Fat intake affects adiposity, comorbidity factors, and energy metabolism of Sprague-Dawley rats. Obesity Res. 10: 956-963   DOI   ScienceOn
21 Azuma, N., K. Yamauchi, and T. Mitsuoka (1984) Bifidus growth-promoting activity of glycomacropeptide derived from human $\kappa$-casein. Agric. Biol. Chem. 48: 2159-2162   DOI
22 Kim, Y. J., S. Park, Y. K. Oh, W. Kang, H. S. Kim, and E. Y. Lee (2005) Purification and characterization of human caseinomacropeptide produced by a recombinant Saccharomyces cerevisiae. Protein Expr. Purif. 41: 441-446   DOI   ScienceOn
23 Blaak, E. E. and W. H. M. Saris (1995) Health aspects of various digestible carbohydrates. Nutr. Res. 15: 1547-1573   DOI   ScienceOn
24 O'Rourke, M. F., R. D. Reidelberger, and T. E. Solomon (1990) Effect of CCK antagonist L364718 on mealinduced pancreatic secretion in rats. Am. J. Physiol. 258: G179-G184   DOI